Title: Immunocompetent in vitro airway models as decision-making tools for pharmacology and toxicology research
Dr. Samuel Constant is co-founder and Chief Executive Officer of Epithelix. He is responsible for the global management and strategic direction of the company’s Swiss and French sites. Samuel has co-authored more than 150 publications and has received 18 awards for scientific achievements, technological innovation, and business development.
